WILEX
WILEX is a biopharmaceutical company developing drugs and diagnostic agents to detect and treat malignant tumors and cancers.
Total raised
€24M
€24,363,000
Funding rounds
2
Investors
1
distinct backers
Active since
1998-12
latest 2010-02
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2010-03-01 | Other | €24M | — | View deal → |
| 1999-01-01 | Other | €0 | Earlybird Venture Capital | View deal → |
Investors
1Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software